98%
921
2 minutes
20
Objectives: The optimal treatment after deterioration following ischemic stroke has not been established in the current guidelines. Therefore, this study evaluated the efficacy of rescue endovascular treatment in patients with early neurological deterioration after acute ischemic stroke.
Methods: This study analyzed data retrospectively retrieved from the electronic medical records at the First Affiliated Hospital of Anhui Medical University.
Results: A total of 20 patients were included in the rescue endovascular treatment group and 23 in the medical group. The 90-day favorable outcome rate in the rescue endovascular treatment group was significantly better than that of the medical group (75.0% 34.8%, =0.031). However, no significant difference in all-cause mortality within 90 days was observed between the rescue endovascular treatment group and the medical group (5.0% 8.7%, =1.000). The 90-day prognosis of patients with mild stroke of anterior circulation and large vessel occlusion who underwent rescue endovascular treatment after deterioration was significantly better than that of those in the medical group (76.5% 31.6%, =0.010).
Conclusion: Rescue endovascular treatment is effective and safe for patients with ischemic stroke and deterioration due to large vessel occlusion, leading to no significant increase in the risk of hemorrhage or death even when the time window exceeds 24 h.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170376 | PMC |
http://dx.doi.org/10.62347/SHIL2671 | DOI Listing |
J Thromb Thrombolysis
September 2025
Department of Neurology, Xianyang Hospital of Yan'an University, Xianyang, 712000, China.
Optimal systolic blood pressure (SBP) targets after endovascular therapy (EVT) for stroke in older adults (≥ 65 years) remain undefined. This study assessed age-stratified associations between early post-EVT SBP (first 6 h) and outcomes. Post hoc analysis of two trials.
View Article and Find Full Text PDFJ Neurointerv Surg
September 2025
Neurology, Neurosurgery and Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA
Purpose: Endovascular treatment of intracranial atherosclerotic disease (ICAD) remains challenging due to procedural risks and stroke recurrence. Previous trials have favored aggressive medical therapy. In patients refractory to medical therapy, 'stentplasty' using expandable and retrievable devices may provide a safer alternative to balloon angioplasty by allowing controlled submaximal vessel dilation without flow arrest.
View Article and Find Full Text PDFInterv Neuroradiol
September 2025
Department of Neurology, University of Texas Rio Grande Valley, Valley Baptist Medical Center, Harlingen, TX, USA.
BackgroundThe safety and efficacy of intravenous thrombolysis (IVT) before mechanical thrombectomy (MT) in acute ischemic stroke remain uncertain.MethodsWe comprehensively searched PubMed, Embase, and the Cochrane Library from inception to May 30, 2025. Randomized controlled trials comparing IVT before MT versus MT alone in acute ischemic stroke were included.
View Article and Find Full Text PDFCureus
July 2025
Cardiovascular Surgery, Kushiro City General Hospital, Kushiro, JPN.
A 65-year-old man presented with Stanford type B aortic dissection complicated by rupture of the distal aortic arch, originating from the false lumen. Due to the short distance between the supra-aortic branches, the lack of peripheral access from malperfusion, and the invasiveness of combined arch and descending aortic replacement via left thoracotomy, emergency total arch replacement with a frozen elephant trunk was chosen to close the primary entry and control the rupture. However, intraoperative deployment of the prosthesis into the false lumen was suspected due to increasing bleeding and transesophageal echocardiographic findings.
View Article and Find Full Text PDFJ Vasc Access
September 2025
Department of Nephrology, West China Hospital/West China School of Medicine, Sichuan University, Chengdu, China.
Superior vena cava (SVC) occlusion in hemodialysis patients presents significant therapeutic challenges, particularly when complicated by stent migration. Sharp recanalization may serve as a salvage intervention for refractory cases though high-risk. Here, we present a 72-year-old male with stent migration-induced recurrent SVC syndrome.
View Article and Find Full Text PDF